FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gary Hoffman

Research Profile

Procedures

Chemicals & Drugs

Anatomy

Sweat

Concepts & Ideas

Phenomena

False Negative Reactions

Physiology

Nutritional Status

Activities & Behaviors

Co-author Network

Publications

TOP 3
Janelle Wells; Michael Anstead; Gary Hoffman; Marjorie Rosenberg; Philip M Farrell
A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
Mei W Baker; Molly Groose; Gary Hoffman; Hara Levy; Michael Rock; Philip M Farrell
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening.
Molly Kloosterboer; Gary Hoffman; Michael Rock; William M Gershan; Anita Laxova; Zhanhai Li; Philip M Farrell
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gary Hoffman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Janelle Wells; Michael Anstead; Gary Hoffman; Marjorie Rosenberg; Philip M Farrell
A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
Pediatrics 2012;129(2):e339-47.
2011: Mei W Baker; Molly Groose; Gary Hoffman; Hara Levy; Michael Rock; Philip M Farrell
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2011;10(4):278-81.
2009: Molly Kloosterboer; Gary Hoffman; Michael Rock; William M Gershan; Anita Laxova; Zhanhai Li; Philip M Farrell
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
Pediatrics 2009;123(2):e338-46.
2007: Sandra C Van Calcar; Linda A Gleason; Heidi Lindh; Gary Hoffman; William Rhead; Gerard Vockley; Jon A Wolff; Maureen S Durkin
2-methylbutyryl-CoA dehydrogenase deficiency in Hmong infants identified by expanded newborn screen.
WMJ : official publication of the State Medical Society of Wisconsin 2007;106(1):12-5.
2007: Anne Marie Comeau; Frank J Accurso; Terry B White; Preston W Campbell; Gary Hoffman; Richard B Parad; Benjamin S Wilfond; Margaret Rosenfeld; Marci K Sontag; John Massie; Philip M Farrell; Brian P O'Sullivan
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
Pediatrics 2007;119(2):e495-518.
2005: Michael J Rock; Gary Hoffman; Ronald H Laessig; Greg J Kopish; Thomas J Litsheim; Philip M Farrell
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
The Journal of pediatrics 2005;147(3 Suppl):S73-7.
2005: Philip M Farrell; HuiChuan J Lai; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Gary Hoffman; Ronald H Laessig; Michael J Rock; Mark L Splaingard
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
The Journal of pediatrics 2005;147(3 Suppl):S30-6.
2003: Zhongxia Qi; Gary Hoffman; Daniel F I Kurtycz; Jingwei Yu
Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(6):458-9.
2003: Don S Lee; Marjorie A Rosenberg; Andrew Peterson; Linda M Makholm; Gary Hoffman; Ronald H Laessig; Philip M Farrell
Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
The Journal of pediatrics 2003;142(6):617-23.
2001: Philip M Farrell; Michael R Kosorok; Michael J Rock; Anita Laxova; L Zeng; Hui-Chuan Lai; Gary Hoffman; Ronald H Laessig; Mark L Splaingard
Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Pediatrics 2001;107(1):1-13.
2000: J B Ciske; Gary Hoffman; K Hanson; K M Annable; J Wolff; T Litsheim; Ronald H Laessig; R Aronson
Newborn screening in Wisconsin: program overview and test addition.
WMJ : official publication of the State Medical Society of Wisconsin 2000;99(2):38-42.
1997: R G Gregg; A Simantel; Philip M Farrell; Rebecca L Koscik; Michael R Kosorok; Anita Laxova; Ronald H Laessig; Gary Hoffman; David J Hassemer; EH Mischler; Mark L Splaingard
Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
Pediatrics 1997;99(6):819-24.